MedPath

石药集团中诺药业(石家庄)有限公司合并

Ownership
-
Established
2002-07-31
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

295

NMPA:295

Drug Approvals

Oseltamivir Phosphate for Suspension

Product Name
磷酸奥司他韦干混悬剂
Approval Number
国药准字H20253827
Approval Date
Apr 8, 2025
NMPA

Ilaprazole Enteric-Coated Tablets

Product Name
艾普拉唑肠溶片
Approval Number
国药准字H20253336
Approval Date
Feb 8, 2025
NMPA

Tedizolid Phosphate Tablets

Product Name
磷酸特地唑胺片
Approval Number
国药准字H20249604
Approval Date
Dec 1, 2024
NMPA

Amphotericin B Liposome for Injection

Product Name
注射用两性霉素B脂质体
Approval Number
国药准字H20244839
Approval Date
Sep 10, 2024
NMPA

Aprepitant Injection

Product Name
阿瑞匹坦注射液
Approval Number
国药准字H20244783
Approval Date
Sep 3, 2024
NMPA

Roxadustat Capsules

Product Name
罗沙司他胶囊
Approval Number
国药准字H20244185
Approval Date
Jun 28, 2024
NMPA

Roxadustat Capsules

Product Name
罗沙司他胶囊
Approval Number
国药准字H20244184
Approval Date
Jun 28, 2024
NMPA

Cefoxitin Sodium for Injection

Product Name
注射用头孢西丁钠
Approval Number
国药准字H20247108
Approval Date
May 20, 2024
NMPA

Peramivir Injection

Product Name
帕拉米韦注射液
Approval Number
国药准字H20243670
Approval Date
May 8, 2024
NMPA

Piperacillin Sodium and Tazobactam Sodium for Injection

Product Name
注射用哌拉西林钠他唑巴坦钠
Approval Number
国药准字H20247056
Approval Date
Mar 22, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 30
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.